LIVE: FDA Cellular, Tissue, and Gene Therapies Advisory Committee Meets on Biologics License for Deramiocel

Live News Network
Live News Network
1.4K followers
30 Video Views·Jul 29, 2026

The FDA Cellular, Tissue, and Gene Therapies Advisory Committee meets at 9:30 a.m. ET on July 29 to discuss and make recommendations on Biologics License Application 125842 from Capricor, Inc. for Deramiocel (human allogeneic cardiosphere-derived cells) in the treatment of cardiomyopathy in Duchenne muscular dystrophy.